Part of the HELP.CH ® Network
Swiss News Now is a news platform with the latest news and information from Swiss companies and Swiss authorities. Latest news from Switzerland in English.
Schlieren (Zurich), Switzerland, October 15, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial performance for the first nine months of 2026.
Pope Leo XIV's recovery from surgery to remove a lower lobe of his lung is "progressing as expected", his doctors have said. The 71-year-old pontiff has started to walk and has "resumed a normal diet" following the roughly 90-minute procedure, the medics said in an update shared by the Vatican. The Pope was diagnosed with lung cancer after the surgery at Rome's Gemelli Hospital on Tuesday afternoon, which the Vatican said had been "successful" and proceeded without complications.
Schlieren/Switzerland - The Board of Directors (‘Board’) of ARYZTA AG will propose Heiner Kamps for election as Chairman of the Board at the Company’s Annual General Meeting (‘AGM’) in May 2027. Mr Kamps has been a member of the Board since 2020 and currently serves as Lead Independent Director. He brings extensive experience in the bakery industry and a deep understanding of ARYZTA and its business.
Romande Energie maintained its firm growth trend in the first six months of 2026. Helped by more supportive conditions in the electricity industry, the Group reaped the benefits of efficiency measures, reorganisation efforts, and better generation and demand forecasting in the period under review. These positive factors resulted in sharply improved operating results, as evidenced by significantly higher EBITDA and EBIT.
The Federal Administrative Court (FAC) has upheld Swisscom’s appeal in the fibre-optic court case and overturned the Competition Commission (COMCO) decision including the CHF 18 million fine. Swisscom does not hold a dominant position in the relevant market as defined by the COMCO. Swisscom welcomes the FAC’s ruling. The judgment is still subject to appeal before the Federal Court.
Basel, Switzerland – At its Capital Markets Day in Vacaville, California, Lonza reports progress of its One Lonza Strategy to deliver long-term, profitable, above-market growth. In less than two years, Lonza has completed its transformation into a pure-play CDMO, following the exit6 of the Capsules & Health Ingredients business and further divestments. Based on stronger operational and financial performance, successful execution of growth projects and attractive future market opportunities, Lonza upgrades its Organic Growth Model.
Zug, Switzerland and Irvine, California – Galderma (SIX: GALD) today announced that it has signed an agreement to acquire ZO® Skin Health, a leading physician- dispensed skincare brand built on clinical science and protocol-based daily care, from its shareholders, including funds managed by Blackstone Tactical Opportunities (“Blackstone”) and the Obagi family.
Geneva – Syz Bank announced today the appointments of Marc Brodard as Head of Private Clients and Martin Freiermuth as Chief Operating Officer. These two high-calibre, senior hires bolster the Bank’s client-facing leadership and operating capabilities, as it continues to invest in its long-term growth.
In the first nine months of 2026 Givaudan recorded sales of CHF 5,891 million, an increase of 5.2% on a Like-for-Like¹ (LFL) basis and an increase of 2.6% in Swiss francs, compared to 5.7% LFL and 1.7% in Swiss francs in 2025.
Steinhausen – The Board of Directors of Schweiter Technologies AG has appointed Stefan Boenders as the new CFO of Schweiter Technologies Group and as a member of the management. Stefan, a Swiss and Belgian citizen, served most recently as CFO and member of the management of the Ricola Group. On 1 November 2026, he will join Schweiter Technologies and succeed Urs Scheidegger, who is set to leave the Group at the end of December 2026, as previously announced.
Baar, Switzerland – Samsung Biologics Co., Ltd. ("Samsung Biologics"), through its direct subsidiary Samsung Peptide AG ("Samsung Peptide"), today published the provisional interim result of its public tender offer (the "Offer") for all publicly held registered shares of PolyPeptide Group AG ("PolyPeptide") (SIX: PPGN).
SwissNewsNow.com is a news platform focused on current developments from Switzerland and part of the
HELP.CH ® network.
The platform provides readers with a compact overview of Swiss news, business developments, company information, innovation, technology and society. Selected content is sourced from the HELP.CH news network and related media platforms.
SwissNewsNow.com helps make important Swiss news accessible through structured publication, search engine visibility and distribution across digital channels.
More about the network:
help.swiss/en
The network includes news platforms such as Aktuellenews.ch, HELP.CH News, Swiss-Press.com, Tagesthemen.ch, Aktuellenews.de and Aktuellenews.at. Together they provide coverage of Swiss business, technology, innovation, society and economic developments.
SwissNewsNow.com brings together selected news and information from across the network, providing readers with a convenient gateway to relevant Swiss topics and current developments.